Conventional monoclonal antibodies cannot reach adequate therapeutic effects in some cases. Enhancing the effector functions is one of the major strategies for the development of engineered monoclonal antibodies to make up for the deficiencies. Here, we will discuss the development of effector function-enhanced antibodies, and the solutions provided by Creative Biolabs.
